SEARCH RESULTS FOR:
Introducing the U.S. Biopharmaceutical Industry
United States Biopharmaceuticals 2019
The moral imperative to innovate.
Doug Giordano
SENIOR VP OF BUSINESS DEVELOPMENT, PFIZER
United States Biopharmaceuticals 2019
Pfizer outlines its plans to build its pipeline through partnerships as the company increasingly focuses on new science.
Hasan Ulusoy
CHAIRMAN, NOBEL İLAÇ
Turkey Pharmaceuticals & Biopharmaceuticals 2020
Nobel is an internationally active pharmaceutical company founded in 1964, representing the Turkish brand in a wide range of geographies.
Michael Gladstone
PRINCIPAL, ATLAS VENTURE
United States Biopharmaceuticals 2019
Atlas Venture is an early-stage venture capital firm that invests in life sciences startup companies in the US.
Jan Krueder & Matthias Vorbeck
CEO, QUÍMICA ANASTACIO & GENERAL MANAGER, ANASTACIO OVERSEAS
Chemical distributer Anastacio sees opportunities for growth across Latin America.
Anthony Hawkshaw, Elsiario Antunez De Mayolo, Eric Caba, Andres Franco
PRESIDENT & CEO, COO & GM, VP PROJECT DEVELOPMENT, VP CORPORATE DEVELOPMENT, BEAR CREEK MINING
Bear Creek Mining is well positioned to begin construction of its Corani project in Peru and explains how financing and local community and government relations have been managed.
Dale Clayton
MANAGING DIRECTOR – CHILE, LIEBHERR
Chile Mining 2020 EXPOMIN Official Investment Guide
Leibherr speaks to GBR about its offering to the mining industry in Chile.
Anita Omoile
MANAGING DIRECTOR & PRESIDENT, DEEP BLUE ENERGY SERVICES
Deep Blue Energy Services was established in Nigeria to bridge the gap between the use of local resources and global best practice.
Jacqueline Bignoumba-llogue
PRESIDENT, UPEGA (ASSOCIATION OF PETROLEUM COMPANIES)
UPEGA, the association that protects the interest of the private sector in Gabon’s oil and gas industry, explains the main challenges confronting its members and how the new mining code needs to be improved.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
MACIG 2025 - Mining in Africa Country Investment Guide
It is said that mining is a patient industry. Current demand projections are not. Demand for minerals deemed ‘critical’ is set to increase almost fourfold by 2030, according to the UN. Demand for nickel, cobalt and lithium is predicted to double, triple and rise ten-fold, respectively, between 2022 and 2050. The world will need to mine more copper between 2018 and 2050 than it has mined throughout history. 2050 is also the deadline to curb emissions before reaching a point of ‘no return.’ The pace of mineral demand and the consequences of not meeting it force the industry to act fast and take more risks. Mining cannot afford to be a patient industry anymore. The scramble for supply drives miners back to geological credentials, and therefore to places like the African Central Copperbelt.
It is said that mining is a patient industry. Current demand projections are not. Demand for minerals deemed ‘critical’ is set to increase almost fourfold by 2030, according to the UN. Demand for nickel, cobalt and lithium is predicted to double, triple and rise ten-fold, respectively, between 2022 and 2050. The world will need to mine more copper between 2018 and 2050 than it has mined throughout history. 2050 is also the deadline to curb emissions before reaching a point of ‘no return.’ The pace of mineral demand and the consequences of not meeting it force the industry to act fast and take more risks. Mining cannot afford to be a patient industry anymore. The scramble for supply drives miners back to geological credentials, and therefore to places like the African Central Copperbelt.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
